HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Sun Selected Research

Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)

7/2021Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area.
1/2021Combining tumor response and personalized risk assessment: Potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
1/2021Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: A large registry-based retrospective study from China.
2/2020Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
11/2019Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study.
1/2019Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.
1/2019An integrated model of the gross tumor volume of cervical lymph nodes and pretreatment plasma Epstein-Barr virus DNA predicts survival of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysis.
1/2019The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity-modulated radiotherapy era.
1/2019Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
1/201910-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Sun Research Topics

Disease

244Neoplasms (Cancer)
10/2022 - 12/2002
204Nasopharyngeal Carcinoma
02/2022 - 11/2004
81Neoplasm Metastasis (Metastasis)
09/2022 - 08/2005
56Inflammation (Inflammations)
07/2022 - 03/2008
36Infections
01/2022 - 12/2002
36Gaucher Disease (Gaucher's Disease)
11/2021 - 10/2005
27Breast Neoplasms (Breast Cancer)
05/2022 - 05/2009
27Carcinogenesis
01/2022 - 01/2010
25Fibrosis (Cirrhosis)
07/2022 - 07/2005
19Glioma (Gliomas)
01/2022 - 11/2012
18Takayasu Arteritis (Arteritis, Takayasu's)
01/2022 - 04/2012
18Hepatocellular Carcinoma (Hepatoma)
01/2021 - 07/2005
17Prostatic Neoplasms (Prostate Cancer)
01/2022 - 09/2006
16Lymphatic Metastasis
04/2021 - 07/2007
15Body Weight (Weight, Body)
02/2021 - 05/2007
13Lysosomal Storage Diseases (Lysosomal Storage Disease)
11/2021 - 10/2005
13Adenocarcinoma
06/2018 - 09/2006
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 03/2008
12COVID-19
01/2022 - 01/2020
12Necrosis
01/2022 - 05/2006
12Carcinoma (Carcinomatosis)
01/2022 - 05/2002
12Myocardial Infarction
03/2021 - 04/2005
12Glioblastoma (Glioblastoma Multiforme)
01/2021 - 08/2007
10Ischemia
01/2022 - 08/2012
10Obesity
01/2022 - 08/2004
10Type 2 Diabetes Mellitus (MODY)
01/2022 - 12/2007
10Mitochondrial Diseases (Mitochondrial Disease)
08/2020 - 01/2013
9Human Influenza (Influenza)
01/2022 - 01/2017
9Squamous Cell Carcinoma of Head and Neck
08/2021 - 03/2015
8Periodontitis
06/2022 - 08/2004
8Hypersensitivity (Allergy)
05/2022 - 05/2010
8Lung Neoplasms (Lung Cancer)
03/2021 - 03/2008
8Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 03/2018
8Atherosclerosis
07/2020 - 06/2015
7Proteinuria
06/2022 - 01/2009
7Colonic Neoplasms (Colon Cancer)
01/2022 - 05/2010
7Triple Negative Breast Neoplasms
01/2022 - 04/2014
7Virus Diseases (Viral Diseases)
10/2021 - 05/2002
7Wounds and Injuries (Trauma)
06/2021 - 05/2012
7Parkinson Disease (Parkinson's Disease)
01/2021 - 06/2011
7Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 12/2002
7Neutropenia
01/2021 - 09/2013

Drug/Important Bio-Agent (IBA)

91Proteins (Proteins, Gene)FDA Link
08/2022 - 08/2005
60Biomarkers (Surrogate Marker)IBA
09/2022 - 07/2005
53DNA (Deoxyribonucleic Acid)IBA
01/2022 - 08/2003
46Pharmaceutical PreparationsIBA
05/2022 - 08/2004
34Messenger RNA (mRNA)IBA
10/2022 - 11/2009
27Cisplatin (Platino)FDA LinkGeneric
01/2022 - 02/2012
22CytokinesIBA
01/2022 - 02/2009
21Therapeutic UsesIBA
12/2021 - 11/2009
21AcidsIBA
05/2020 - 05/2002
19Biological ProductsIBA
01/2022 - 02/2010
19MicroRNAs (MicroRNA)IBA
10/2021 - 06/2012
16Glucose (Dextrose)FDA LinkGeneric
03/2022 - 02/2008
15EnzymesIBA
02/2021 - 05/2010
15Glucosylceramidase (Glucocerebrosidase)IBA
01/2020 - 10/2005
14Peptides (Polypeptides)IBA
01/2022 - 12/2002
14CollagenIBA
01/2022 - 01/2009
14LigandsIBA
01/2022 - 08/2005
14Glucosylceramides (Glucocerebrosides)IBA
10/2020 - 02/2010
14GlucosidasesIBA
05/2020 - 07/2010
13Phosphotransferases (Kinase)IBA
02/2022 - 09/2006
12RNA (Ribonucleic Acid)IBA
05/2022 - 06/2003
12ErbB Receptors (EGF Receptor)IBA
03/2022 - 02/2010
12SaposinsIBA
05/2020 - 10/2005
11VaccinesIBA
01/2022 - 05/2013
11Small Interfering RNA (siRNA)IBA
01/2022 - 01/2012
11Interleukin-6 (Interleukin 6)IBA
01/2022 - 04/2012
11CateninsIBA
12/2021 - 08/2014
11sphingosyl beta-glucosideIBA
10/2020 - 03/2010
11Atrial Natriuretic Factor (ANF)IBA
04/2012 - 11/2006
10AntigensIBA
10/2021 - 12/2002
10Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 04/2007
10Fluorouracil (Carac)FDA LinkGeneric
01/2019 - 02/2012
10atrial natriuretic factor prohormone (31-67)IBA
08/2010 - 09/2006
9ProgranulinsIBA
01/2022 - 09/2015
8AntioxidantsIBA
06/2022 - 10/2013
8Long Noncoding RNAIBA
03/2022 - 01/2015
8LipopolysaccharidesIBA
01/2022 - 04/2008
8Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 12/2005
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 02/2009
8Peptide Hydrolases (Proteases)FDA Link
01/2021 - 09/2010
8AntibodiesIBA
02/2020 - 06/2003
8methoxypolyethyleneglycol- poly(lactic- co- glycolic acid)IBA
02/2019 - 06/2012
8atrial natriuretic factor precursor (79-98)IBA
04/2009 - 09/2006
7GlucansIBA
05/2022 - 11/2017
7Docetaxel (Taxotere)FDA Link
01/2022 - 04/2014
7Indicators and Reagents (Reagents)IBA
01/2022 - 05/2014
7PlatinumIBA
01/2022 - 01/2017

Therapy/Procedure

110Therapeutics
08/2022 - 08/2004
83Radiotherapy
10/2022 - 03/2006
80Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
07/2021 - 04/2007
48Chemoradiotherapy
01/2022 - 04/2007
44Drug Therapy (Chemotherapy)
03/2022 - 02/2010
40Induction Chemotherapy
01/2022 - 10/2015
16Neoadjuvant Therapy
10/2019 - 01/2015
11Aftercare (After-Treatment)
01/2022 - 05/2006
7Ligation
05/2022 - 01/2007
7Immunotherapy
03/2022 - 12/2002
7Precision Medicine
11/2021 - 01/2017